Q1 2025 Ardent Health Partners Inc Earnings Call Transcript
Key Points
- Ardent Health Partners Inc (ARDT) reported a solid quarter with a 7.6% increase in admissions, driven by strong underlying growth and a heightened flu season.
- The company is well-positioned for long-term growth, focusing on market share expansion, outpatient and acute care hospital footprint growth, and operational initiatives.
- First quarter revenue increased by 4% to $1.5 billion, with adjusted EBITDA growing by 2.5% to $98 million.
- Ardent Health Partners Inc (ARDT) successfully integrated 18 Nextcare urgent care clinics, which is expected to generate additional downstream volumes in key markets.
- The company has a strong liquidity position with $495 million in cash and a favorable least adjusted net leverage ratio of three times.
- The growth rate of physician professional fees remains a headwind, although there are signs of moderation.
- There was a notable increase in payer claim denials compared to the first quarter of 2024, impacting year-over-year comparisons.
- Outpatient surgeries declined by 2.3% in the first quarter, partially due to the timing of leap year.
- The strategic transfer of certain oncology and infusion services to a health system partner tempered revenue growth by approximately 70 basis points.
- The company is awaiting final CMS approval for the 2025 New Mexico DPP program, which could impact financial results if delayed.
Ladies and gentlemen, thank you for standing by and welcome to the Ardent Health Partners first quarter 2025 earnings conference call. (Operator Instructions)
As a reminder, today's call is being recorded. I will now hand today's call over to David Styblo, senior Vice President of Investor relations. Please go ahead.
Thank you, operator, and welcome to Ardent Health's first quarter 2025 earnings conference call. Joining me today is Ardent President and Chief Executive Officer, Marty Bonick and Chief Financial Officer, Alfred Lumsdaine. Marty and Alfred will provide prepared remarks, and then we will open the line to questions.
Before I turn the call over to Marty, I want to remind everyone that today's discussion contains forward-looking statements about future business and financial expectations.
Actual results may differ significantly from those projected in today's forward-looking statements due to various risks and uncertainties, including the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
